Secondary coenzyme Q deficiency in neurological disorders

Free Radic Biol Med. 2021 Mar:165:203-218. doi: 10.1016/j.freeradbiomed.2021.01.017. Epub 2021 Jan 12.

Abstract

Coenzyme Q (CoQ) is a ubiquitous lipid serving essential cellular functions. It is the only component of the mitochondrial respiratory chain that can be exogenously absorbed. Here, we provide an overview of current knowledge, controversies, and open questions about CoQ intracellular and tissue distribution, in particular in brain and skeletal muscle. We discuss human neurological diseases and mouse models associated with secondary CoQ deficiency in these tissues and highlight pharmacokinetic and anatomical challenges in exogenous CoQ biodistribution, recent improvements in CoQ formulations and imaging, as well as alternative therapeutical strategies to CoQ supplementation. The last section proposes possible mechanisms underlying secondary CoQ deficiency in human diseases with emphasis on neurological and neuromuscular disorders.

Keywords: Brain; Coenzyme Q; Mitochondria; Muscle; Neurological diseases; Secondary coenzyme Q deficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ataxia
  • Humans
  • Mitochondrial Diseases* / genetics
  • Muscle Weakness
  • Tissue Distribution
  • Ubiquinone* / deficiency
  • Ubiquinone* / metabolism

Substances

  • Ubiquinone

Supplementary concepts

  • Coenzyme Q10 Deficiency